Early Sepsis Indicator Biomarker
Help identify adult patients in the emergency department (ED) who have sepsis or are at increased risk of developing sepsis with the exclusive Early Sepsis Indicator (ESId). The only FDA-cleared hematology biomarker for sepsis, ESId measures monocyte distribution width (MDW) to support prompt clinical decision making for this often-deadly condition. This sepsis parameter is available as part of a routine CBC with differential, enabling automatic reporting without added workload burden.
Article Monocyte Distribution Width Adds Value to Sepsis Detection
Learn about a clinical study evaluating the diagnostic accuracy of monocyte distribution width for early sepsis detection.Read article
Webinar Sepsis Overview: Challenges and Solutions for Laboratories
Learn about the clinical sepsis global healthcare crisis. Discover the challenges to early identification, and the role of the laboratory to understand the sepsis markers used for detection and monitoring.View on demand
REMISOL Advance is a trademark or registered trademark of Normand-Info SAS in the United States and other countries. Used under license.